Aurobindo Pharma USA Inc 2026-08-12 Health serious FDA
Health · FDA · Recall #FDA-D-0733-2026
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by:… Recall
Issued August 12, 2026 · Aurobindo Pharma USA Inc
In August 2026, Aurobindo Pharma USA Inc recalled the Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by:…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
shortfill; reports of empty capsules.
What you should do
- 1 Stop using Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Aurobindo Pharma USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Aurobindo Pharma USA Inc
- Category
- Health
- Recall date
- August 12, 2026
- Units affected
- Not reported
- Sold at
- US Nationwide.
- Recall number
- FDA-D-0733-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Aurobindo Pharma USA Inc has 4 recalls in our database, including 1 rated Critical.
- We're tracking 3,707 Health recalls in our database.
- This is the 487th Health recall we've logged in 2026.